FINWIRES · TerminalLIVE
FINWIRES

Market Chatter: Dexus to See Limited Balance Sheet Impact From Court Ruling on Melbourne Airport, Citigroup Says

By

Dexus (ASX:DXS) will see only a limited direct impact to its balance sheet from a New South Wales Supreme Court ruling that triggers a compulsory sale process for its stake in Melbourne Airport at market value, Citigroup said in a note, the Australian Financial Review reported Monday.

The court on Friday ruled that the company was in violation of confidentiality agreements and must dispose of the interest. Dexus holds a roughly 27.3% stake in Australia Pacific Airports, which owns Melbourne's Tullamarine airport and the Launceston airport in Tasmania.

Citi analyst Penny Howard said the investment is housed within Dexus' funds management platform and is excluded from net tangible asset calculations, which mitigates the balance sheet impact, according to the report.

"While near-term sentiment is likely to remain negative, a final resolution of the APAC matter - whether through appeal or a negotiated outcome - would represent a meaningful step forward for investors seeking a recovery and sustainable earnings growth trajectory in the medium term," AFR quoted Howard as saying.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Related Articles

Asia

Genrix Grants CQ Pharmaceutical Distribution Rights for Myeloma Drug in China, Hong Kong, Macau, Taiwan

Chongqing Genrix Biopharmaceutical (SHA:688443) granted C.Q. Pharmaceutical (SHE:000950) subsidiary Yaoyou Pharmaceutical exclusive development and distribution rights for the GR1803 drug across China and Hong Kong, Macau, and Taiwan.The agreement covers development such as clinical trials, research, and manufacturing, as well as sales, the filing said.The GR1803 velitumimumab drug is indicated for multiple myeloma, a rare form of blood cancer.Yaoyou will pay Genrix up to 600 million yuan in initial payment, listing milestone, and technology transfer milestone payments.Genrix will also be eligible to receive sales royalties of up to a minimum percentage of two digits.

SHA:688443SHE:000950
Asia

Xuan Wu Cloud's CFO Steps Down

Xuan Wu Cloud Technology's (HKG:2392) Chief Financial Officer Ge Ping resigned to devote more time to personal affairs effective May 31, according to a Friday Hong Kong bourse filing.

HKG:2392
Asia

Update: Xi'an Eswin Materials Technology to Invest Up to 40 Million Yuan in Glassmaker's Funding Round

Xi'an Eswin Materials Technology (SHA:688783) will invest up to 40 million yuan in a pre-A+ funding round for Zhuhai Yiyuan Technology, according to a Friday filing with the Shanghai bourse.Zhuhai Yiyuan Technology seeks to raise between 100 million yuan and 200 million yuan in a funding round.The glass manufacturer plans to use the proceeds for capacity expansion, equipment procurement, and technology upgrades.

SHA:688783